首页|PD-1在2型糖尿病肾病外周血T淋巴细胞中的表达与临床意义

PD-1在2型糖尿病肾病外周血T淋巴细胞中的表达与临床意义

The expression and clinical significance of serum PD-1 on T lymphocytes in patients with type 2 diabetic kidney disease

扫码查看
目的:旨在调查2 型糖尿病肾病(DKD)患者外周血 T淋巴细胞上程序性死亡受体1(PD-1)的表达及意义.方法:研究纳入 80 例健康人群作为NC组,80 例首诊2 型糖尿病(T2DM)患者作为T2DM组,80 例2 型DKD的患者作为DKD组,其中DKD组根据尿蛋白肌酐比(UACR)分为中度升高组(A2DKD组,UACR:30~300 mg·g-1)和重度升高组(A3DKD组,UACR:>300 mg·g-1)2 个亚组,每个亚组各40 例.比较各组外周血T淋巴细胞亚群PD-1 的表达,评估肾小球滤过率(eGFR)、肌酐(Scr)及UACR与杀伤性T淋巴细胞PD-1 表达的相关性.比较非奈利酮治疗前后DKD组杀伤T淋巴细胞PD-1 的表达率.结果:总T淋巴细胞亚群PD-1 表达率、辅助T细胞亚群PD-1 表达率、杀伤T细胞亚群PD-1 表达率和双阴性T细胞亚群PD-1 表达率在3 组间比较差异有统计学意义(P<0.05).进一步对亚组PD-1 表达率分析发现,A3DKD组的杀伤T细胞亚群的PD-1 表达率明显高于A2DKD组与T2DM组(均P<0.05).杀伤T细胞亚群的PD-1表达率与UACR水平(r=0.243,95%CI:0.024~0.439)和Scr水平(r=0.507,95%CI:0.323~0.654)均呈正相关(均P<0.05),与eGFR水平呈负相关(r=-0.263,95%CI:-0.456~-0.046,P=0.02).药物治疗后,DKD患者杀伤T细胞亚群PD-1 表达率显著下降,差异有统计学意义(P=0.03).结论:外周血杀伤T细胞亚群PD-1 表达升高可导致DKD进展,杀伤T细胞亚群PD-1 表达率可作为评估病情的生物学指标.
Objective:To investigate the expression and significance of programmed death receptor 1(PD-1)on T lymphocytes in patients with type 2 diabetic kidney disease(DKD).Methods:80 healthy controls(NC group),80 first diagnosis of type 2 diabetes mellitus patients(T2DM group),and 80 type 2 DKD patients(DKD group)were included in this study.According to urinary albumin creatinine ratio(UACR),the DKD group was divided into two subgroups,moderately elevated group(A2DKD group,UACR:30-300 mg·g-1)and severely elevated group(A3DKD group,UACR:>300 mg·g-1),with 40 cases in each subgroup.The expression rate of PD-1 on T lymphocytes subsets in peripheral blood were compared among the three groups.The correlation of estimated glomerular filtration rate(eGFR),serum creatinine(Scr)and UACR with expression rate of PD-1 on killer T lymphocytes was evaluated,and the expression rate of PD-1 on killer T lymphocytes of DKD patients before and after finerenone treatment were compared.Results:The expression rates of PD-1 in total T lymphocyte subset,helper T cell subset,killer T cell subset,and double negative T cell subset showed significant differences among the three groups(P<0.05).Further analysis of the expression rate of PD-1 in subgroups was found the expression rate of PD-1 in the killer T cell subset in the A3DKD group was significantly higher than that in the A2DKD group and T2DM group(all P<0.05).The expression rate of PD-1 in killer T cells was positively correlated with UACR(r=0.243,95%CI:0.024-0.439)and Scr levels(r=0.507,95%CI:0.323-0.654)(all P<0.05),but negatively correlated with eGFR level(r=-0.263,95%CI:-0.456--0.046,P=0.02).After drug treatment,the expression rate of PD-1 in killer T cell subsets of DKD patients was significantly decreased(P<0.05).Conclusion:Increased expression of PD-1 in peripheral blood killer T cell subsets can lead to the progression of DKD,the rate of PD-1 expression in killer T cell subsets can be used as a biological indicator to evaluate the disease.

programmed death receptor 1type 2 diabetes mellitusdiabetic kidney diseaseT lymphocyte subsetclinical significance

王冠怡、沈婷、居悦俊、孔颖宏

展开 >

南通大学附属常熟医院 内分泌科,江苏 常熟 215500

程序性死亡受体1 2 型糖尿病 糖尿病肾病 T淋巴细胞亚群 临床意义

2024

现代医学
东南大学

现代医学

CSTPCD
影响因子:0.703
ISSN:1671-7562
年,卷(期):2024.52(12)